文献速递胸部肿瘤

IASLC肺癌分期项目:非小细胞肺癌切缘状态与残留肿瘤描述符分析

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2019-11-13

本研究在14712例接受切除的NSCLC患者中验证残留肿瘤(R)描述符的预后价值,包括IASLC提出的不确定切除R(un)定义。按修订标准重新分类后,R0、R(un)、R1、R2的中位生存分别为未达到、33个月、29个月;在淋巴结阳性病例中,R0、R(un)、R1的中位生存分别为70、50、30个月,R(un)预后介于R0与R1之间。

要点

  • R(un)预后介于R0与R1之间,支持其作为独立残留肿瘤描述符。
  • 淋巴结阳性病例中R0、R(un)、R1中位生存分别为70、50、30个月。
  • R状态与T、N分期相关,详细评估R因素对辅助治疗临床试验重要。

核心结论

  • R描述符具有预后相关性,R(un)的生存分层介于R0与R1之间。
  • 详细评估R因素对辅助治疗临床试验的设计和分析尤为重要。

研究设计与样本

  • 回顾性分析14712例接受切除且R状态与生存数据完整的NSCLC患者。
  • 评估修订的R0、R(un)、R1、R2分类对生存的影响。

主要发现

  • 初始分类:14293例R0,263例R1,156例R2,中位生存分别为未达到、33个月、29个月。
  • 9290例(63%)探查至少3个N2站,6641例(45%)行肺叶特异性淋巴结清扫,与pN2增加相关。
  • 364例有数据中62例(17%)存在囊外侵犯;942例(6.4%)最高站阳性。
  • 1705例胸水灌洗细胞学检查中59例(3.5%)阳性;13例支气管切缘原位癌。
  • 因56%病例淋巴结分期不充分重新分配后:6070例R0,8185例R(un),301例R1,156例R2。

关键数值与推荐

  • R(un)定义涉及淋巴结分期不充分等因素,重新分配后56%病例归为R(un)。
  • 淋巴结阳性病例中R(un)与R0生存差异显著(p<0.0001),R1与R(un)差异显著(p<0.001)。

临床怎么用

  • 临床应详细评估切缘状态、淋巴结清扫范围等R相关因素以准确分类。
  • 在辅助治疗临床试验设计中应考虑R(un)对预后的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our aim was to validate the prognostic relevance in NSCLC of potential residual tumor (R) descriptors, including the proposed International Association for the Study of Lung Cancer definition for uncertain resection, referred to as R(un). METHODS: A total of 14,712 patients undergoing resection with full R status and survival were analyzed. The following were also evaluated: whether fewer than three N2 stations were explored, lobe-specific nodal dissection, extracapsular extension, highest lymph node station status, carcinoma in situ at the bronchial resection margin, and pleural lavage cytologic examination result. Revised categories of R0, R(un), R1, and R2 were tested for survival impact. RESULTS: In all, 14,293 cases were R0, 263 were R1, and 156 were R2 (median survivals not reached, 33 months, and 29 months, respectively). R status correlated with T and N categories. A total of 9290 cases (63%) had three or more N2 stations explored and 6641 cases (45%) had lobe-specific nodal dissection, correlated with increasing pN2. Extracapsular extension was present in 62 of 364 cases with available data (17%). The highest station was positive in 942 cases (6.4%). The pleural lavage cytologic examination result was positive in 59 of 1705 cases (3.5%): 13 had carcinoma in situ at the bronchial resection margin. After reassignment because of inadequate nodal staging in 56% of cases, 6070 cases were R0, 8185 were R(un), 301 were R1, and 156 were R2. In node-positive cases, the median survival times were 70, 50, and 30 months for R0, R(un) (p < 0.0001), and R1 (p < 0.001), respectively, with no significant difference between R0 and R(un) in pN0 cases. CONCLUSIONS: R descriptors have prognostic relevance, with R(un) survival stratifying between R0 and R1. Therefore, a detailed evaluation of R factor is of particular importance in the design and analyses of clinical trials of adjuvant therapies.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Edwards JG, Chansky K, Van Schil P, et al. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer. J Thorac Oncol. 2019. PMID: 31731014. doi:10.1016/j.jtho.2019.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。